SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-127725
Filing Date
2022-12-16
Accepted
2022-12-16 13:39:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2232918_defa14a.htm DEFA14A 11217
  Complete submission text file 0001104659-22-127725.txt   12215
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35737 | Film No.: 221467505
SIC: 2834 Pharmaceutical Preparations